A detailed history of E. Ohman J:Or Asset Management Ab transactions in Dexcom Inc stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 15,700 shares of DXCM stock, worth $1.03 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
15,700
Previous 15,700 -0.0%
Holding current value
$1.03 Million
Previous $2.18 Billion 18.26%
% of portfolio
0.04%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $125,642 - $154,110
1,100 Added 7.53%
15,700 $2.18 Billion
Q4 2023

Feb 15, 2024

SELL
$75.49 - $124.16 $256,665 - $422,144
-3,400 Reduced 18.89%
14,600 $1.81 Billion
Q3 2023

Feb 06, 2024

BUY
$86.06 - $137.93 $1.55 Million - $2.48 Million
18,000 New
18,000 $1.68 Billion
Q2 2023

Apr 05, 2024

BUY
$112.47 - $130.98 $134,964 - $157,176
1,200 Added 7.14%
18,000 $2.31 Billion
Q2 2022

Apr 05, 2024

BUY
$67.99 - $132.89 $856,673 - $1.67 Million
12,600 Added 300.0%
16,800 $1.25 Billion
Q1 2022

Apr 05, 2024

SELL
$94.08 - $130.2 $6.95 Million - $9.62 Million
-73,871 Reduced 94.62%
4,200 $2.15 Billion
Q4 2021

Apr 05, 2024

SELL
$129.87 - $162.82 $2.21 Million - $2.77 Million
-17,040 Reduced 17.92%
78,071 $41.9 Billion
Q3 2021

Apr 05, 2024

SELL
$106.71 - $143.18 $452,450 - $607,083
-4,240 Reduced 4.27%
95,111 $52 Billion
Q2 2021

Apr 05, 2024

BUY
$80.99 - $107.93 $5.14 Million - $6.85 Million
63,500 Added 177.12%
99,351 $42.4 Billion
Q1 2021

Apr 05, 2024

BUY
$84.79 - $104.74 $873,337 - $1.08 Million
10,300 Added 40.31%
35,851 $12.9 Billion
Q4 2020

Apr 05, 2024

BUY
$78.0 - $104.5 $756,600 - $1.01 Million
9,700 Added 61.19%
25,551 $9.45 Billion
Q3 2020

Apr 05, 2024

BUY
$95.51 - $112.95 $238,775 - $282,375
2,500 Added 18.73%
15,851 $6.53 Billion
Q2 2020

Apr 05, 2024

SELL
$62.68 - $105.34 $2.33 Million - $3.92 Million
-37,220 Reduced 73.6%
13,351 $5.41 Billion
Q1 2020

Apr 05, 2024

BUY
$47.79 - $75.63 $2.08 Million - $3.3 Million
43,620 Added 627.54%
50,571 $13.6 Billion
Q4 2019

Apr 05, 2024

SELL
$36.62 - $57.29 $29,295 - $45,832
-800 Reduced 10.32%
6,951 $1.52 Billion
Q3 2019

Apr 05, 2024

SELL
$35.53 - $43.8 $37,235 - $45,902
-1,048 Reduced 11.91%
7,751 $1.16 Billion
Q2 2019

Apr 05, 2024

BUY
$27.84 - $38.92 $41,342 - $57,796
1,485 Added 20.3%
8,799 $1.32 Billion
Q1 2019

Apr 05, 2024

SELL
$28.07 - $38.18 $784,135 - $1.07 Million
-27,935 Reduced 79.25%
7,314 $871 Million
Q4 2018

Apr 05, 2024

BUY
$26.99 - $37.37 $951,370 - $1.32 Million
35,249 New
35,249 $4.22 Billion
Q4 2017

Apr 05, 2024

SELL
$11.12 - $15.38 $23,352 - $32,298
-2,100 Closed
0 $0
Q3 2017

Apr 05, 2024

BUY
$11.36 - $18.98 $1,136 - $1,898
100 Added 5.0%
2,100 $103 Million
Q4 2016

Apr 05, 2024

SELL
N/A
-12,600
2,000 $119 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.